Drug Shortage Report for TEVA-NYSTATIN

Last updated on 2025-02-06 History
Report ID 218955
Drug Identification Number 02194201
Brand name TEVA-NYSTATIN
Common or Proper name TEVA-NYSTATIN 100MU/ML DROPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NYSTATIN
Strength(s) 100000UNIT
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging size 1L
ATC code A07AA
ATC description INTESTINALANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-07
Estimated end date 2025-03-10
Actual end date
Shortage status Actual shortage
Updated date 2025-02-06
Company comments Under Allocations
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v36 2025-02-06 French Compare
v35 2025-02-06 English Compare
v34 2025-01-30 French Compare
v33 2025-01-30 English Compare
v32 2025-01-09 French Compare
v31 2025-01-09 English Compare
v30 2024-12-04 French Compare
v29 2024-12-04 English Compare
v28 2024-12-04 English Compare
v27 2024-11-28 French Compare
v26 2024-11-28 English Compare
v25 2024-11-21 French Compare
v24 2024-11-21 English Compare
v23 2024-11-14 French Compare
v22 2024-11-14 English Compare
v21 2024-11-08 French Compare
v20 2024-11-08 English Compare
v19 2024-10-24 French Compare
v18 2024-10-24 English Compare
v17 2024-10-11 French Compare

Showing 1 to 20 of 36